ILD: Diagnosis and Subtypes (Part Two)
ILD: Diagnosis and Subtypes (Part Two) tammytilley@gm… Mon, 09/15/2025 – 10:08 Image By downloading this material, I acknowledge that it […]
Google News
Spyre Doses First Patient in Phase 2 Trial for Rheumatic Diseases | SYRE Stock News
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in
Google News
Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial By Investing.com
The rheumatic conditions targeted by the SKYWAY trial affect more than 3 million individuals in the United States, according to
Google News
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of …
SPY072 is a potential first- and best-in-class anti-TL1A antibody for rheumatic diseases targeting quarterly or twice-yearly subcutaneous dosing …
RheumNow
What are the Pros and Cons of autologous CAR T cell therapy? Summary slide from Georg Schett who also mentioned the exc
What are the Pros and Cons of autologous CAR T cell therapy? Summary slide from Georg Schett who also mentioned
RheumNow
In lupus patients presenting with demyelinating symptoms, consider a probable disease overlap between NPSLE and NMOSD.
In lupus patients presenting with demyelinating symptoms, consider a probable disease overlap between NPSLE and NMOSD. https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Mon, 09/15/2025
RheumNow
Different B cells depletion strategies in SARDs highlighted by Georg Schett From low and short lived depletion achieved
Different B cells depletion strategies in SARDs highlighted by Georg Schett From low and short lived depletion achieved https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john…
RheumNow
Juvenile Lupus: some new mechanistic data Circulating Treg population are expanded in SLE and in particular in Lupus Ne
Juvenile Lupus: some new mechanistic data Circulating Treg population are expanded in SLE and in particular in Lupus Ne https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg
RheumNow
PAH, when associated with ILD in CTD, worsens prognosis, and poses challenges for treatment Summary of when PAH should
PAH, when associated with ILD in CTD, worsens prognosis, and poses challenges for treatment Summary of when PAH should https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg
RheumNow
Dr. Alberta Hoi graphically presents the difference bet acute confusional states & chronic cognitive changes in #lup
Dr. Alberta Hoi graphically presents the difference bet acute confusional states & chronic cognitive changes in #lup https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg john+RNV2@john… Mon,
RheumNow
How to treat CTD ILD? A comparative slide summarizing ACR/BSR and EULAR treatment guidelines Emphasis on combination
How to treat CTD ILD? A comparative slide summarizing ACR/BSR and EULAR treatment guidelines Emphasis on combination https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg john+RNV2@john… Mon,
Google News
Spyre doses first patient in phase 2 SKYWAY trial of SPY072, first anti-TL1A antibody for …
… 2 SKYWAY basket trial of SPY072, the first anti-TL1A antibody studied in rheumatic diseases … -September 15, 2025 at
Google News
Andersson lesions in ankylosing spondylitis | Clinical Rheumatology
On examination, spinal mobility was reduced, but there were no neurological deficits. Laboratory tests revealed an elevated C-reactive protein level …
RheumNow
When Myositis Hits the Lungs: What Every Rheumatologist Should Know About ILD
When Myositis Hits the Lungs: What Every Rheumatologist Should Know About ILD aggarwalr@upmc.edu Mon, 09/15/2025 – 08:00
Google News
Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial – StreetInsider
Spyre Therapeutics doses first patient in phase 2 rheumatic disease trial. September 15, 2025 8:00 AM. Spyre Therapeutics Inc. (NASDAQ:
The Rheumatologist
Oral Treatment for PsA Inches Closer to FDA Approval
The FDA will consider a supplemental new drug application for deucravacitinib for the treatment of adults with active psoriatic arthritis
PubMed
Personalized Platelet Transfusion Predictions for Neonates
JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.14389. Online ahead of print. NO ABSTRACT PMID:40952725 | DOI:10.1001/jama.2025.14389
PubMed
Impact of Biologic Therapy, School Success, Parent’s Education and Socioeconomic Status on Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Their Parents
Indian Pediatr. 2025 Sep 15. doi: 10.1007/s13312-025-00188-1. Online ahead of print. ABSTRACT OBJECTIVE: To evaluate the effect of biologic therapy,
PubMed
Global, regional, and national burden of early-onset ischemic heart disease: trends and projections among adults aged 15-44 years from 1990 to 2046
Front Cardiovasc Med. 2025 Aug 29;12:1653335. doi: 10.3389/fcvm.2025.1653335. eCollection 2025. ABSTRACT BACKGROUND: Ischemic heart disease (IHD) among young adults represents
PubMed
Short-term longitudinal clinical, biochemical, and quality of life outcomes of medical or surgical therapy in unilateral primary aldosteronism
Front Endocrinol (Lausanne). 2025 Aug 29;16:1558837. doi: 10.3389/fendo.2025.1558837. eCollection 2025. ABSTRACT CONTEXT: Unilateral primary aldosteronism (uPA) is a surgically curable
PubMed
CRISPR typing and phage content of colonizing Group B Streptococci from healthy Egyptian women
Front Cell Infect Microbiol. 2025 Aug 28;15:1636071. doi: 10.3389/fcimb.2025.1636071. eCollection 2025. ABSTRACT BACKGROUND: Streptococcus agalactiae or Group B Streptococcus (GBS)
PubMed
Incomplete Susac Syndrome With Recurrent Retinal Occlusions and Vertigo: A Case of Early Immunosuppressive Success
Cureus. 2025 Aug 14;17(8):e90088. doi: 10.7759/cureus.90088. eCollection 2025 Aug. ABSTRACT Susac syndrome (SS) is a rare autoimmune microangiopathy that targets
PubMed
Safety of Anesthesia With Dexmedetomidine for Muscle and Nerve Biopsy – A Review of 100 Cases
Cureus. 2025 Aug 12;17(8):e89859. doi: 10.7759/cureus.89859. eCollection 2025 Aug. ABSTRACT Pain during muscle and nerve biopsies is a distressing complication
PubMed
Anti-TIF1-Gamma Autoantibodies-Positive Juvenile Dermatomyositis Associated With Interstitial Lung Disease: A Case Report
Cureus. 2025 Aug 12;17(8):e89905. doi: 10.7759/cureus.89905. eCollection 2025 Aug. ABSTRACT Juvenile dermatomyositis (JDM) is a rare autoimmune disease in children,
PubMed
An Unusual Presentation of Henoch-Schönlein Purpura With Penile Involvement in a 10-Year-Old Boy From Mexico
Cureus. 2025 Aug 14;17(8):e90076. doi: 10.7759/cureus.90076. eCollection 2025 Aug. ABSTRACT Immunoglobulin A (IgA) vasculitis, also known as Henoch-Schönlein purpura, is
PubMed
Microbial community profiles in breast cancer and normal adjacent tissues: associations with clinicopathological characteristics
Transl Cancer Res. 2025 Aug 31;14(8):5093-5108. doi: 10.21037/tcr-2025-1570. Epub 2025 Aug 28. ABSTRACT BACKGROUND: The microorganisms in breast tissue and
PubMed
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment
J Gastrointest Oncol. 2025 Aug 30;16(4):1366-1379. doi: 10.21037/jgo-2025-30. Epub 2025 Aug 16. ABSTRACT BACKGROUND: Esophageal squamous cell carcinoma (ESCC) presents